Loading...
Improved glycaemic control and treatment satisfaction with a simple wearable 3‐day insulin delivery device among people with Type 2 diabetes
AIM: To evaluate the PAQ (®) (CeQur SA, Horw, Switzerland), a wearable 3‐day insulin delivery device that provides set basal rates and bolus insulin on demand, in people with Type 2 diabetes. METHOD: Adults with Type 2 diabetes with HbA(1c) concentrations ≥53 and ≤97 mmol/mol (7.0 and 11.0%) while t...
Saved in:
| Published in: | Diabet Med |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
John Wiley and Sons Inc.
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6175230/ https://ncbi.nlm.nih.gov/pubmed/29888811 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dme.13708 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|